Loading...

Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 58.47 AUD +0.29% Market Closed
Updated: Dec 8, 2022

Intrinsic Value

The intrinsic value of one PME stock under the Base Case scenario is 16.8 AUD. Compared to the current market price of 58.47 AUD, Pro Medicus Ltd is Overvalued by 71%.

The Intrinsic Value is calculated as the average of the two valuation methods:

PME Intrinsic Value
Base Case
16.8 AUD
Overvaluation 71%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

PME Profitability Score
Profitability Due Diligence

Pro Medicus Ltd's profitability score is 90/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Exceptional 1-Year Revenue Growth
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
90/100
Profitability
Score

Pro Medicus Ltd's profitability score is 90/100. The higher the profitability score, the more profitable the company is.

PME Solvency Score
Solvency Due Diligence

Pro Medicus Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Long-Term Liabilities
Low D/E
Short-Term Liabilities
73/100
Solvency
Score

Pro Medicus Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
100%
Gross Margin
66%
Operating Margin
47%
Net Margin
56%
FCF Margin
48%
ROE
68%
ROIC
Other

PME Capital Structure
Pro Medicus Ltd

Market Capitalization 6.1B AUD
Total Debt 1.7M AUD
Minority Interest 0 AUD
Preferred Equity 0 AUD
Cash and Equivalents 63.7M AUD
Short-Term Investments 26.9M AUD
Enterprise Value 6B AUD

Wall St
Price Targets

PME Price Targets Summary
Pro Medicus Ltd

Wall Street analysts forecast PME stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PME is 55.6 AUD with a low forecast of 37.02 AUD and a high forecast of 65.1 AUD.

Lowest
Price Target
37.02 AUD
37% Downside
Average
Price Target
55.6 AUD
5% Downside
Highest
Price Target
65.1 AUD
11% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

PME Competitors
Pro Medicus Ltd

PME Suppliers & Customers
Pro Medicus Ltd

Pro Medicus Ltd has 4 key suppliers from 2 countries and 2 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Banking industry.

Pro Medicus Ltd has 4 key customers from 2 countries and 3 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Banking industry.

Shareholder Return

PME Price
Pro Medicus Ltd

1M 1M
+10%
6M 6M
+38%
1Y 1Y
+0%
3Y 3Y
+160%
5Y 5Y
+674%
Annual Price Range
58.47
52w Low
37.7755
52w High
62.9248
Price Metrics
Average Annual Return 49.7%
Standard Deviation of Annual Returns 35.91%
Max Drawdown -43%
Shares Statistics
Market Capitalization 6.1B AUD
Shares Outstanding 103 380 000
Percentage of Shares Shorted
N/A

Company Profile

Pro Medicus Ltd

Country

Australia

Industry

Health Care

Market Cap

6.1B AUD

Dividend Yield

0.4%

Description

Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. The company is headquartered in Richmond, Victoria. The company went IPO on 2000-10-10. The firm products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a Radiology Information Systems (RIS) medical software for practicing of management, training, installation and professional services, after sale support and service products, Promedicus.net secure email and Integration products. Its Visage 7.0 is a healthcare imaging software that provides radiologists and clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images, Picture Archive and Communication System (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and professional services and support products.

Contact

VICTORIA
RICHMOND
Richmond, 450 Swan St
+61394298800.0
http://www.promed.com.au/

IPO

2000-10-10

Employees

-

Officers

Co-Founder, CEO, MD & Exec. Director
Dr. Sam Aaron Hupert M.B.B.S., M.D.
Co-Founder, Technology Director & Exec. Director
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc.
CFO & Company Sec.
Mr. Clayton James Hatch CPA, B.Comm, CPA
GM of Europe & Global CTO
Dr. Malte Westerhoff
GM of North America & Global Head of Marketing
Mr. Brad Levin
Global Head of Sales - Visage Imaging Inc
Mr. Sean Lambright
Show More
Global Head of Customer Service of Visage Imaging Inc.
Ms. Teresa Gschwind
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one PME stock?

The intrinsic value of one PME stock under the Base Case scenario is 16.8 AUD.

Is PME stock undervalued or overvalued?

Compared to the current market price of 58.47 AUD, Pro Medicus Ltd is Overvalued by 71%.